
The vast majority of the patients who take statins don’t ever have to worry about the side effect of muscle symptoms. Even among those who do experience muscle damage, with […]
The Division of Rheumatology is a thriving clinical and academic center, which concentrates clinically on providing the most outstanding care to patients affected by a variety of common and uncommon rheumatic disorders.
This is an unusual time, and this year’s LEAP reflects it well: we start with Covid-19’s very sickest patients, and a Hopkins-wide team’s groundbreaking efforts to illuminate an unusual response in their immune system.
We end with a remarkable patient with a rare autoimmune disease: the legendary musician, Peter Frampton, who is not only raising awareness and research funding, but changing medical advice about how to preserve muscle function.
Alice in Wonderland may come to mind as you read this issue of LEAP, because we are moving from the large to the small, and back again: A rheumatic disease is big, and its effect can be devastating. However, a disease such as rheumatoid arthritis, scleroderma, or Sjögren’s is, in fact, multiple diseases, each slightly different.